Summary
Mylan Pharmaceuticals Inc. will have to face antitrust claims that it conspired with other drugmakers to inflate generic drug prices after a federal judge found sufficient evidence that the company participated in the conspiracy.
Judge Michael P. Shea of the US District Court for the District of Co…
No source URL found
Exclusive AI-Powered News Insights (For Members only)
Disclaimer:This content is AI-generated from various trusted sources and is intended for informational purposes only. While we strive for accuracy, we encourage you to verify details independently. Use the contact button to share feedback on any inaccuracies—your input helps us improve!
